Show simple item record

dc.contributor.authorYe, Xin
dc.contributor.authorTam, Wai Leong
dc.contributor.authorShibue, Tsukasa
dc.contributor.authorKaygusuz, Yasemin
dc.contributor.authorNg Eaton, Elinor
dc.contributor.authorReinhardt, Ferenc
dc.contributor.authorWeinberg, Robert A
dc.date.accessioned2018-07-13T16:26:49Z
dc.date.available2018-07-13T16:26:49Z
dc.date.issued2015-09
dc.date.submitted2014-12
dc.identifier.issn0028-0836
dc.identifier.issn1476-4687
dc.identifier.urihttp://hdl.handle.net/1721.1/116979
dc.description.abstractTumour-initiating cells (TICs) are responsible for metastatic dissemination and clinical relapse in a variety of cancers. Analogies between TICs and normal tissue stem cells have led to the proposal that activation of the normal stem-cell program within a tissue serves as the major mechanism for generating TICs. Supporting this notion, we and others previously established that the Slug epithelial-to-mesenchymal transition-inducing transcription factor (EMT-TF), a member of the Snail family, serves as a master regulator of the gland-reconstituting activity of normal mammary stem cells, and that forced expression of Slug in collaboration with Sox9 in breast cancer cells can efficiently induce entrance into the TIC state. However, these earlier studies focused on xenograft models with cultured cell lines and involved ectopic expression of EMT-TFs, often at non-physiological levels. Using genetically engineered knock-in reporter mouse lines, here we show that normal gland-reconstituting mammary stem cells residing in the basal layer of the mammary epithelium and breast TICs originating in the luminal layer exploit the paralogous EMT-TFs Slug and Snail, respectively, which induce distinct EMT programs. Broadly, our findings suggest that the seemingly similar stem-cell programs operating in TICs and normal stem cells of the corresponding normal tissue are likely to differ significantly in their details.en_US
dc.description.sponsorshipBreast Cancer Research Foundationen_US
dc.description.sponsorshipSamuel Waxman Cancer Research Foundationen_US
dc.description.sponsorshipLudwig Center for Molecular Oncology at MITen_US
dc.description.sponsorshipNational Cancer Institute (U.S.).(Program P01-CA080111)en_US
dc.description.sponsorshipNational Cancer Institute (U.S.).(Program R01-CA078461)en_US
dc.description.sponsorshipNational Cancer Institute (U.S.).(Program U01-CA184897)en_US
dc.publisherSpringer Natureen_US
dc.relation.isversionofhttp://dx.doi.org/10.1038/NATURE14897en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourcePMCen_US
dc.titleDistinct EMT programs control normal mammary stem cells and tumour-initiating cellsen_US
dc.typeArticleen_US
dc.identifier.citationYe, Xin, Wai Leong Tam, Tsukasa Shibue, Yasemin Kaygusuz, Ferenc Reinhardt, Elinor Ng Eaton, and Robert A. Weinberg. “Distinct EMT Programs Control Normal Mammary Stem Cells and Tumour-Initiating Cells.” Nature 525, no. 7568 (September 2015): 256–260.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.departmentMassachusetts Institute of Technology. Division of Comparative Medicineen_US
dc.contributor.mitauthorReinhardt, Ferenc
dc.contributor.mitauthorWeinberg, Robert A
dc.relation.journalNatureen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2018-07-12T17:04:55Z
dspace.orderedauthorsYe, Xin; Tam, Wai Leong; Shibue, Tsukasa; Kaygusuz, Yasemin; Reinhardt, Ferenc; Ng Eaton, Elinor; Weinberg, Robert A.en_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0002-0895-3557
mit.licensePUBLISHER_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record